Jane Street’s Trillium Therapeutics Inc. TRIL Stock Holding History

Jane Street’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-170,100	Closed	-$2.99M	–	11231
2021 Q3	$2.99M	Buy	170,100 +155,200	+1,042%	+$1.81M	﹤0.01%	3668
2021 Q2	$144K	Sell	14,900 -42,500	-74%	-$400K	﹤0.01%	9070
2021 Q1	$615K	Sell	57,400 -24,700	-30%	-$305K	﹤0.01%	6428
2020 Q4	$1.21M	Sell	82,100 -40,100	-33%	-$578K	﹤0.01%	4358
2020 Q3	$1.73M	Buy	+122,200	New	+$1.22M	﹤0.01%	3263

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Jane Street's TRIL Position: Q4 2021 in Review

Jane Street sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 173,761 shares — an estimated $3.05M sold.

Jane Street first reported a position in TRIL in Q4 2016 and held it in 10 quarters. The position peaked at $3.05M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Jane Street reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Jane Street sold 173,761 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $3.05M.
Jane Street first reported a position in Trillium Therapeutics Inc. in Q4 2016 and held it in 10 quarters.
Jane Street's Trillium Therapeutics Inc. position peaked at $3.05M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Jane Street's 13F filing for Q4 2021, filed 15 Feb 2022.